Related Experiment Video

Updated: Aug 24, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Update on the systemic treatment of malignant melanoma

David H Lawson1

  • 1Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA.

Seminars in Oncology
|May 5, 2004
PubMed

Insights

Recent advances in melanoma treatment include new staging systems and sentinel node biopsy. Ongoing trials explore novel therapies, but interferon remains standard for high-risk patients, with dacarbazine and IL-2 for stage IV disease.

Area of Science:

  • Oncology
  • Dermatology
  • Clinical Trials

Background:

  • Melanoma treatment has seen significant progress, yet challenges remain.
  • Accurate staging is crucial for effective melanoma management.
  • Systemic therapies are vital for advanced melanoma.

Purpose of the Study:

  • To review recent advancements in melanoma systemic treatment.
  • To discuss current challenges and disappointments in melanoma therapy.
  • To highlight ongoing clinical trials for melanoma patients.

Main Methods:

  • Review of recent literature on melanoma treatment.
  • Analysis of new staging systems and diagnostic procedures.
  • Overview of ongoing clinical trials evaluating novel therapeutic agents.

Main Results:

  • New American Joint Committee on Cancer staging and sentinel node biopsy improve melanoma staging.
  • Interferon is the established adjuvant therapy for high-risk melanoma.
  • Dacarbazine and high-dose IL-2 are FDA-approved for stage IV melanoma; new agents are under investigation.

Conclusions:

  • Melanoma treatment continues to evolve with new therapeutic strategies.
  • Participation in clinical trials is encouraged for melanoma patients to access novel treatments.
  • Despite advances, effective systemic treatments for advanced melanoma are still a focus of research.

More Related Videos

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...